trial

Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations

NCTId NCT00042159
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by Yale University
Primary completion 2003-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2002-07
Primary completion
2003-07
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2003-07
Status
COMPLETED
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Hallucinations
indication
Hallucinations
indication